<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 335 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page334.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=335">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 335 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 335</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=335"><img src="../thumb/335.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>298 / 2020-04                                                           Endocrine System - 19.5
   Thrombocytopen: 0,5 mg/kg.   Dosage: Indiv.accord.to dis., sev.& pt. respons./ tol. Slow IM/IV   CELESTONE SOLUSPAN, MSD [N/P/S in C]
   Organ transplantat: 50-100 mg at time of surg. Maint: 10-20 mg/  infus.or inject.in dos.equiv.to 4-20 mg. May also be given by loc.  Betamethasone as betamethasone sodium phos. 3 mg, betametha-
   day incr.if reject.threaten.  inject.into soft tiss.in dos.equiv.to 4-8 mg.  sone acetate 3 mg/ml.
   Contraindications: Pept.ulc., osteoporos., psychos./sev.psycho-  Contraindications: Syst.fung.infects., pept. ulcerat., osteoporos.,   Indications: Sev./ac.rheumat.dermatolog.& allerg. condits.
   neuros., ac.bact.infect., vir. infect., immunisat., lactat.  psychos., sev. psychoneuros., act.TB, ac.vir. infects., live vaccine   (S4) INJ, G2963.
   Side effects: Electrol.disturbs., induc.CF, excess. metabol. eff., incr.  vaccinat., pregn.& lactat.  712785-001: 10x1 ml vials, R838,02
   appetit., delay.wound heal., pept. ulcerat./ haemorrh./perforat., incr.  Side effects: Adren.cort.hyperactiv., ac.adren. insuffic.dur.prolong.  713171-006: 1x2 ml vial, R167,61
   suscept.to infect., ac.adren.insuffic., large dos.may produce sympt.   treatm., excess metabol.eff., delay.wound heal., incr.suscept.to in-  711231-002: 1x5 ml vial, R419,02
   typic.of hyperactiv.of adren.cortex., ment.& neurolog. disturbs.,   fects., growth retardat.in childr., electrol.bal.disturbs., ment.& neu-  Dosage: Indiv.accord.to condit.& respons. IM admin. for system.eff.
   amenorrh., IC-hypertens., polyarterit., thromboembol.complicat.,   rolog.disturbs., amenorrh., hyperhidros., IC hypertens., ac.pancreatit.,   Intra-artic./per-articul./ intrabursal/intraderm & intrales for loc eff.
   may mask infect., reduct.in lymphocyt.  asept.bone necros., thrombo-embol.complicat., musc.weakn., may   IM admin.respons.condits egs.are collag.dis/ dermatolog.condits
   Special precautions: CHF, diab.mellit., infect. dis., chron.ren.fail.,   mask signs of infect., foet./neonat.adren. suppress.dur.pregn., revers.  & resp.tract disords.. Init. treatm. for most condits.with 1 ml rep.
   uraem., elderly, quiesc.TB, neonates born to mothers who receiv.  cushingoid sympts. with high dos., poss.osteoporos.& spontan.fract.,   wkly/more oft.if necess. Low.dos.gen.suffic.in less sev.dis., 2 ml in
   large dos. dur. pregn., ulcerat.colit.where intestin.perforat.& peri-  N2 deplet., hyperglycaem., thin.of skin.  sev.dis.decr.dos. grad.aft.long-term use., admin loc. anaesthet. (if
   tonit. poss., grad.withdr.   Special precautions: Monit.pt.dur.long cours., insul.req.of dia-  reqd.) prior.to Celestone as separate inj., Sev.illn.poss.req.init.2 ml
   Drug interactions: Reduc.eff.with barbits., phenylbutazone, phe-  bet.& antihypertens.req.may be incr., CCF, hypertens., diabet.mellit.,   Resp.tract disord: 1-2 ml IM at wkly.interv.
   nytoin., rifampicin.reduc. respons. to anticoag.  epilep., glauc., infect.dis., chron.ren.fail., uraem., elderly, quiescent.  Rheumat.& osteo arthrit: Intra-articul.admin. Very large joints:
                                TB should rec.chemoprophylax.if corticoster.ther.is prolong., syrup   1-2 ml. Large joints: 1 ml. Med.joints: 0,5-1 ml. Small joints:
   BETADEXAMINE,(Aspen Pharmacare)    cont.gluc.& sucrose     0,25-0,5 ml.
   Pharmacare [N/P/S in C]      Drug interactions: Eff.reduc.by barbits., phenytoin, rifampicin,   Bursit: Intraburs.inj.admin.of 1 ml. Sev.inj.at 1-2 wk interv.usually
   Betamethasone 0,25 mg, dexchlorpheniramine mal. 2 mg/5 ml.  carbamazepine & primidone, K-deplet.diuret.may cause excess.K   reqd.in recur.ac.& exacerbat.of chron.bursit.,
          nd
   Indications: 2  line ther.when antihistamin.are not effect in   loss, decr. salicyl.serum conc., NSAID’s incr.GI bleed.& ulcerat.,   Tendinit/myosit./fibrosit./tenosynovit./peritendinit.& per-
   short term allerg.rhinit.treatm., steroid respons.dermatologic.al-  antimuscarin.effs.decr.in mysth.grav., respons.to anticoags.may   articul.inflamm.condits: 3-4 loc .inj.of 1 ml each at 1-2 wk.interv.
   lerg.& dermatos.             be reduc./enhanc.             Intraderm./intrales.treatm: Admin.0,2 ml/cm 2  intraderm.
   (S4) LIQ. A40/21.5.4/0623    Warnings: Not for intrathec./subconjunctiv.inj., poss tox.effs.from   Deposit.a uniform.depot of medicat. Tot.amnt inj.at all sites wkly
   3000025-001: 100 ml, R187,84  withdr.or cont.use, poss.CV collapse with rapid massive IV inject.  not to exceed 1 ml.
   Dosage: Indiv. Do not exceed recomm.max. treatm. For short term   Ganglions of joint caps: 0,5 ml inject.direct.into cyst.
   treatm.of less than 5 days only. For only well defin.indicat. Not to   CELESTAMINE, MSD [N/P/S in C]  Burist.under heloma durum: 2 success.inj.of 0,25 ml each.
   be mix.with other mixtures.  Betamethasone 0,25 mg, dexchlorpheniramine mal. 2 mg/tab   Contraindications: Syst.fung.infects., corticoster. hypersens.,
   Adults & childr.over 12 yrs: 5-10 ml 4xdly. Max.40 ml/day. Reduc.  or 5 ml syrup.  weigh anticipat.clinic.improvem. against poss.undesir.effs.in cert.
   dos.grad.as improvm. Occurs. Do not rep. course within 28 days un-  Indications: Ac.allerg.rhinit.not respons.to convent. ther., steroid   condit.ordinarily consid.contra-indic.(eg.osteoporos./mark.emot.
   less spec.indicat. Not for childr.&lt;12 yrs.  respons.dermatologic. allerg. & dermatos.  instabil./pept.ulc./TB/ac.ocul.H.simplex/thromboembol.tenden./
   Contraindications: Ingred.& racem.chlorphenam. hypersens,   (S4) TABS, [N/P/S in C] G2951  diverticulit/rec.intestin.anastom./ac.& chron.infects), safety in
   newborn & prems., MAOI, syst.fung. infects., safety not est.in   713066-017: 30, R263,21  pregn.& lactat.not est.
   childr.&lt;12 yrs., glauc.      Dosage: Indiv. 1-2 tabs 4xdly.Max.8 tabs/day for max.5 days.  Side effects: Na retent., K loss, hypokalaem. alkalos., fluid retent.,
   Side effects: Incr.infect.risk, gen.allerg.reacts., decr.body growth,   (S4) SYRUP. [N/P/S in C] G2954.  CHF in suscept.pts., hypertens., musc.weakn, corticoster.myopathy,
   Cushing’s syndr., hyperglycaem., adrenocortic.insuffic., Na & fluid   713058-006: 120 ml, R285,98  musc. mass loss, myasth.grav.sympt.aggrav., osteoporos., vertebr.
   retent., negat.prot./nitrog.& calcium bal., hypokalaem., depress.,   Dosage: Indiv. Do not exceed recomm.max.treatm. For short term   compress.fract., asept.necros. of femoral & humeral heads, patholog.
   euphor., nervousn., restlessn., cataracts., glauc., hypertens., pulm.TB,   treatm.of less than 5 days only. For only well defin.indicat. Not to be   fract.of long bones, tend.rupt., joint instability, hiccups, pept. ulc.with
   gastric.irrit., N&V, dyspeps., incr.appet., indigest., pancreatit., pept.  mix.with other mixtures. Adults & childr.over 12 yrs: 5-10 ml 4xdly.   poss.subseq.perforat.& haemorrh., pancreatit., abdom.distent., ul-
   ulc., atroph.skin condit., imp.skin heal., osteoporos., fluid & electrol.  Max.40 ml/day. Reduc.dos.grad.as improvm. occurs to min.maint.&   cerat.oesophagit., imp. wound heal., skin atrophy, thin fragile skin,
   disturb., bld dyscras., haemolyt.anaem., hypersens.reacts., somnol.,   discont.if poss. Do not rep. course within 28 days unless spec.indicat.  petechiae, ecchymos., fac.erythema, incr.sweat., suppress. skin
   slight drowsin., lassit., dizzin., inco-ordinat., headache, psychomot.  Contraindications: Syst.fung.infects., newborn & prems., MAOI,   test react., allerg.dermatit., urticar., angioneurot. oed., convuls.,
   impairm., convuls., trem., sleep disturbanc., confus., paraesthes.,   safety in childr.not est.  incr,IC-press., vertigo, headache, menstr.irregul., Cushingoid state,
                                Side effects: Fluid & electrol.disturbs., GI/ musculoskelet./der-
   neurit., extrpyramid.effs., blurr.vis., tinnit., card. dysrhythm., palpi-  foet. intrauter./childhood growth suppress., second. adrenocortic.&
   tat., hypotens., mucus thicken., dry nas.mucos, constipat., incr.gastric   matolog./neurolog./endocr./ophthalm.incl.blurr.vis./metabol.&   pituit.unresponsiven., decr. carbohydr. tol., manifestat.of latent diab.
                                psych.disturbs., HPA-axis suppress., incr.calcium excret., post. sub-
   reflux, xerostom., diarrh., epigastr.pain, jaund., skin rash, hair loss,   mellit., incr. insul./oral hypoglycaem.requirem.post. subcaps. cata-
   sweat., urticar., malag., urin.diffic./ retent.  capsul. cataracts/glauc.& second.fung.or vir. ocul. infects.enhanc.  racts, incr.IOP, glauc., exophthalmos, blurr. vis., negat.N 2 bal., euphor.,
                                with prolong.ther., thrombo-embol. complicat., musc.weakn., CNS/
   Warnings and special precautions: Poss. Cushingoid signs/  mood swings, sev. depress.to frank psychot.manifestat., personalit.
   growth & developm.retard.with prolong.high dos.ther.incr.suscept.  CV/ haematolog./ GU & resp.effs., chills, dry mouth/ nose & throat.  changes, insomn., hypotens./shock-like reacts., anaphylactoid/hy-
                                Warnings and special precautions: Replacem. ther.to prev.
   to stress and adren.cris, pts.undergo.stress with signs of HPA-ax-  adren.crisis in pts.undergo.stress with signs of HPA-axis suppress.,   persens.reacts., rare blindn. assoc.with intrales.ther.around face &
   is suppress., ulcerat.colit., incr.IOP, act/latent pept.ulc., abscess./  ulcerat.colit., act/ latent pept.ulc., abscess./pyogen.infect., act.TB,   head, hyper-/hypopigmentat., subcutan.& cutan. atrophy, sterile
   pyogen.infect., act.TB, syst fung. infect., ren.fail., hypertens., os-  syst. fung.infect., ren.fail., hypertens., osteoporos., hyperthyroid.,   abscess., post-inj.flare, charcot-like arthropathy.
   teoporos., hyperthyroid., cirrhos., ocul.H.simpl.infect., glauc., diver-  cirrhos., ocul.H.simpl.infect., refer.to opthalmolog.to eval.poss.vis.  Warnings and special precautions: Not for IV/ SC use, ser.neu-
   ticulos., fresh intestin.anastamos., myasth. grav., CHF, diab.mellit.,   disturbs.causes, numb. & motility of spermatozoa poss.alt., signs   rolog.events.incl.death report.with epidur. inj.& safety & effectiven.
   dizzin./sedat.& hypotens. esp.in pts.over 60 yr., elderly, may aggrav.  of infect. mask., diverticulos., fresh intestin. anastamos., myasth.  of epidur.admin. not est & corticoster.not approv.for this use, rare
                                                              anaphylactoid/anaphylact.reacts/shock, asept. techniq. mandat., not
   exist. emot. instabil./psychot.tendenc., consid.diet.salt restrict.& K   grav., CHF, diab.mellit., elderly, may aggrav.exist.emot.instabil./
   supplem, post.subcapsul.cataracts & enhanc.second.ocul.infects.  psychot. tendenc., consid.diet.salt restrict.& K supplem, concom.   indict.for hyaline membr.dis. management & should not be admin.to
                                                              pregn. women, IM admin.with idiopath.thrombocytopen. purpura,
   due to fungi/vir.with prolong use, masks signs of infect., concom.  acetylsalic.acid in hypoprothrombinaem, smallpox vaccinat.&
   aspir. with corticoster.in hypoprothrombinaem., smallpox vacci-  other vaccinat.should not be undertak.concom., narr.angle glauc.,   IM inj.of corticoster.to be giv.deep into large musc.mass.to avoid
                                                              loc.tiss.atrophy, syst. effs. poss.with soft tiss./intrales.& intra-artic.
   nat. & other vaccinat.should not be undertak. concom., thrombo   stenos. pept.ulc., pyloroduod.obstruct., prostat. hypertrophy, bladd.
   embol.complic., musc.weakn., pyloroduod.obstruct., prostat. hy-  neck obstruct., CV dis.incl. hypertens., IOP, hyperthyroid., eval.risk   admin., excl.sept.process/inj.into prev.infect.joint, do not inj.into un-
                                                              stable joints,/infect.areas/ intervertebr. spaces, rep.inj.into osteo-
   pertrophy, bladd. neck obstruct., CV dis.incl.hypertens., hyperthy-  vs.benef. for admin.dur.pregn./nurs.women or women of child bear.  arthrit.joint poss. incr.joint destruct., avoid inj.into subst.of tendon
   roid., avoid in narr.angle glauc., epilep., S/E poss.affect.ability to   age, observ.newborns of mothers who receiv.subst.corticoster.dos.  as delay tend.rupt.result., pt.to avoid overuse of joint.follow.intra-
   drive/perform hazard. tasks, safety in pregn.& lactat.not est., ob-  dur.pregn.for hypoadrenal., syrup contains tartrazine, determ.effs.  artic.ther., prev.hist.of drug allergy, with long-term corticoster.ther.
   serv. newborns of mothers who receiv.subst. corticoster. dos.dur.  bef.driv./operat.machin.  tfd.to oral admin.should be consid., monit.for up to 1 yr. aft. cessat.
   pregn.for hypoadrenal., motility & number of spermatozoa poss.  Drug interactions: CNS depress.potent.sedat. eff., bld.salicyl.conc.  of long-term/high dos.ther., signs of infect. poss.mask., post.sub-
   alt., contains sugar & sweetn.  decr., somatotropin respons. inhib., phenobarbit./phenytoin/rifampic   caps.cataracts/glauc. with poss.opt.nerve damage & enhancem.of
   Interactions: MAOI poss.exacerb.CNS depress. eff.& anticholinerg.  or ephedr. reduc.steroid eff., oestrog.incr.steroid eff., K-deplet. diu-  second. fung./vir.ocul.infects.with prolong.ther., consid. poss.diet.
   eff., phenobarbit./phenytoin/ rifampic or ephedr.reduc.steroid eff.,   ret./card.glycosides/digital.or amphotericin B incr. hypokalaem.,   salt restrict.& K  supplement., vaccinat. should not be undertaken
                                                                     +
   oestrog.incr. steroid eff., K-deplet.diuret./digox.& amphotericin B   coumar.type anti-coag.incr.PTT, NSAID’s aggrav.ulcerogen.eff., dos.   while on corticoster. ther.& pts.on immunosuppress. corticoster.
   incr.hypokalaem., coumar.type anti-coag.incr. PTT, NSAID’s aggrav.  adjustm.with anti-diabet.agents, dexchlorpheniram. mal.decr.PI with   dos.to avoid chickenpox/measles expos., when used in act.TB use
   ulcerogen.eff., dos.adjustm. with anti-diabet.agents/insul., eff.of   oral anticoags., CYP3A4 inhibit.poss.incr.system.corticoster.S/E  in conjunct.with appropr. anti-TB regimen & observe pt.closely, in la-
   other anti-coags. either incr./decr., alcoh./CNS depress.potent.se-  tent TB/tubercul.react.pts.TB chemoprophylax. reqd., use low. poss.
   dat. eff., sedat.effs.potent.by anticholinerg., bld.salicyl. conc.decr.,   dos., grad.withdr.to minim. drug-induc. second.adrenocortic.insuffic.,
   somatotropin respons.inhib.                                effs. enhanc.in hypothyroid./cirrhos., ocul.H simplex, emot. instabil.,
   BETANOID, (Aspen Pharmacare: Pharma) Pharmacare            psychot.tendenc., non-specif. ulcerat. colit., diverticulit., fresh intes-
   [N/P/S in C]                       Certain medicines (i.e.   tin. anastomos., act./latent pept.ulc., ren.insuffic., hypertens., oste-
   Betamethasone.                      those that cause CNS   oporos., myasth.grav., monit.child. growth & developm., motility &
   Indications: Inflam.condits.where steroid.is indic.        numb.spermatozoa poss.alt., consid.referr.to ophthalmolog.in case
                                                              of vis. disturbs., monit.ser.electrol.partic.K , concom. acetylsalicyl.
                                                                                +
   (S4) SYRUP. 27/21.5.1/0491. 0,60 mg/5 ml.  depression) may lead to
   826936-008: 100 ml, R63,18                                 acid in hypoprothrombinaem.
                                                              Interactions: Barbit./phenytoin/rifampicin  or ephedr. reduc.the
   Dosage: Indiv.accord.to dis., sev.& pt.respons. Usual. 0,6-4,8 mg   drowsiness and impaired
   dly in div.dos.                     concentration, which   eff., poss.excess.effs.with oestrog., poss.excess.K-loss with K-
                                                              deplet.diuret., card. glycos.may enhanc.poss.arrhyth./digital.toxic.
   (S4) TABS. 27/21.5.1/0543.                                 assoc. with hypokalaem., K -deplet.with amphotericin B enhanc.,
                                                                          +
   826928-005: 0,5 mg, 20, R72,23      may be aggravated by   coumar.anti-coags.effs. incr./ decr., incr.occur./severit.of GI ulcerat.
   826928-013: 0,5 mg, 100, R361,27                           with NSAID’s or alcoh., bld.salicyl.conc.decr., poss.dos. adjustm.of
   Dosage: Indiv.accord.to dis., sev.& pt.respons. Usual dos.range:   the simultaneous intake   antidiabet., respon.to somatotrop. inhibit., concom.strong CYP3A4
   0,5-5 mg dly.in div.dos. Tot.dly. maint.dos.can be admin.once   of alcohol or other   inhibits.poss.incr. expos./ sytem.S/E, false negat.bact.infect result.
   early in morn.                                             (nitro-blue tetrazolium test)
   (S4) INJ 30/21.5.1/0324. 4 mg/ml.  central nervous system
   Indications: Adren.insuffic.states prior to surg. or if shock/sev.  COVOCORT, (AI Pharm Ltd) Premier
   trauma or stress condits.occur, inflamm.condits.respons.to corti-  depressant agents.  Hydrocortisone.
   coster.therapy.                                            Indications: Addison’s dis., chron.adrenocort. insuff.second.to
   839361-009: 10 amps, R297,93                               hypopituitar.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page334.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>&nbsp;&nbsp;&nbsp;<a href="page331.html">331</a>&nbsp;&nbsp;&nbsp;<a href="page332.html">332</a>&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>&nbsp;&nbsp;&nbsp;<a href="page334.html">334</a>&nbsp;&nbsp;&nbsp;<a href="page335.html">335</a>&nbsp;&nbsp;&nbsp;<a href="page336.html">336</a>&nbsp;&nbsp;&nbsp;<a href="page337.html">337</a>&nbsp;&nbsp;&nbsp;<a href="page338.html">338</a>&nbsp;&nbsp;&nbsp;<a href="page339.html">339</a>&nbsp;&nbsp;&nbsp;<a href="page340.html">340</a>
             </td>
             <td width="35%"><a href="page336.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page336.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
